Skip to main content
. 2020 Jan 22;13:25–33. doi: 10.2147/CEG.S239343

Table 4.

Efficacy of Second Therapy in Patients Who Failed Their First Therapy

CLA Triple Therapy LEVO Triple Therapy Bismuth Quadruple Therapy P-value
Patients who underwent second therapy 0 14 19 0.001
Successful second treatment (%) 0 (0) 5 (35.7) 11 (57.9) 0.208
Combined patients undergoing therapy (first and second treatments) 97 77 36 0.001
Overall successful treatment (%) 76 (78.3) 36 (46.7) 18 (50) 0.001